Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
Saama was recognized as a winner in the TransCelerate SCOPE ClinEco Solve Challenge for best integration of Risk-Based Quality Management (RBQM) into the protocol review process. This recognition highlights our innovative Agentic AI–driven protocol digitalization solution, which helps clinical teams digitize and standardize historical and active study protocols, assess study design risks earlier, and make smarter, faster decisions across the trial lifecycle.
The ClinEco Solve Challenge celebrates solutions that transform protocol review by promoting digital, standards-based, and user-centric approaches. ClinEco’s mission is to accelerate clinical development by enabling teams to identify risks, reduce complexity, and improve patient and site outcomes early in the study design process. Saama’s solution stood out for its ability to digitize historical and active protocols, standardize content, and deliver actionable insights across the trial lifecycle, helping sponsors make data-driven decisions while minimizing delays and errors.
This award highlights Saama’s Agentic AI vision, where intelligent agents work alongside human experts to streamline workflows, surface risks early, and support smarter trial designs. By integrating protocol intelligence with study design benchmarks and regulatory standards, our solution empowers clinical teams to reduce manual effort, optimize study protocols, and accelerate timelines, all while maintaining high standards of quality and compliance.
This achievement reinforces our mission to accelerate clinical trials and bring life-changing treatments to patients faster through intelligent, human-centered AI innovation.
Discover Saama’s Agentic AI platform:
